Exhibit 99.4
Unaudited Pro Forma Condensed and Combined Financial Information
The following unaudited pro forma condensed and combined financial statements have been prepared to give effect to the acquisition by Ebix, Inc. (“Ebix” or the “Company”) of A.D.A.M., Inc. (“ADAM”). These pro forma combined financial statements are derived from the historical consolidated financial statements of Ebix which are incorporated by reference into this document, and the audited historical financial statements of ADAM which are included with this current report as Exhibit 99.3. The pro forma condensed and combined statement of for the year ended December 31, 2010 include twelve months of operating results for ADAM. These historical financial statements have been adjusted as described in the notes to the unaudited pro forma combined financial statements.
The unaudited pro forma combined balance sheet has been prepared assuming the acquisition of ADAM occurred on December 31, 2010. The unaudited pro forma combined statement of income has been prepared assuming the acquisition of ADAM occurred on January 1, 2010. In all cases the purchase method, which requires an allocation of the purchase price to assets acquired and liabilities assumed at their fair value, has been applied to the accounting for the acquisition of ADAM. Basic and diluted earnings per share and weighted average shares outstanding have retroactively adjusted to reflect the Ebix 3-for-1 stock split that was effective on January 4, 2010.
The unaudited pro forma combined financial statements are for informational purposes only and are not intended to represent or be indicative of the consolidated results of operations or financial position that would be reported had the acquisition of ADAM been completed as of the dates presented.No effect has been given in these pro forma financial statements for future synergistic benefits that may be realized through the combination of the two companies or costs that may be incurred by integrating their operations. The unaudited pro forma condensed and combined financial statements should not be considered representative of the Company’s future consolidated results of operation or financial position nor should the historical results operations be indicative of our future expected results of operations.
Ebix, Inc. and Subsidiaries
Unaudited Pro Forma Condensed and Combined Statements of Income
for the Year Ending December 31, 2010
(In thousands, except per share data)
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | Ebix/ADAM | |
| | As Reported | | | Audited | | | Adjustments | | Combined & Adjusted | |
| | Ebix, Inc. | | | ADAM | | | Amount | | | Ref | | Pro Forma | |
Operating revenue | | $ | 132,188 | | | $ | 27,583 | | | | | | | | | $ | 159,771 | |
| | | | | | | | | | | | | | | | | | |
Operating expenses: | | | | | | | | | | | | | | | | | | |
Costs of services provided | | | 29,599 | | | | 3,374 | | | | | | | | | | 32,973 | |
Product development | | | 13,607 | | | | 4,775 | | | | | | | | | | 18,382 | |
Sales and marketing | | | 6,372 | | | | 7,843 | | | | | | | | | | 14,215 | |
General and adminstrative | | | 24,065 | | | | 2,904 | | | | 1,380 | | | L | | | 28,349 | |
Amortization and depreciation | | | 6,038 | | | | 2,336 | | | | 1,555 | | | D | | | 9,929 | |
| | | | | | | | | | | | | | |
Total operating expenses | | | 79,681 | | | | 21,232 | | | | 2,935 | | | | | | 103,848 | |
| | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
Operating income | | | 52,507 | | | | 6,351 | | | | (2,935 | ) | | | | | 55,923 | |
Interest income | | | 519 | | | | — | | | | | | | | | | 519 | |
Interest expense | | | (902 | ) | | | (312 | ) | | | 312 | | | E | | | (902 | ) |
Other non-operating income | | | 6,319 | | | | — | | | | | | | | | | 6,319 | |
Foreign exchange gain (loss) | | | 1,211 | | | | — | | | | | | | | | | 1,211 | |
| | | | | | | | | | | | | | |
Income before income taxes | | | 59,654 | | | | 6,039 | | | | (2,623 | ) | | | | | 63,070 | |
Income tax provision | | | (635 | ) | | | (1,648 | ) | | | 404 | | | H | | | (1,879 | ) |
| | | | | | | | | | | | | | |
Net income | | $ | 59,019 | | | $ | 4,391 | | | $ | (2,219 | ) | | | | $ | 61,191 | |
| | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
Basic earnings per share | | $ | 1.69 | | | | | | | | | | | | | $ | 1.59 | |
Diluted earnings per share | | $ | 1.51 | | | | | | | | | | | | | $ | 1.43 | |
| | | | | | | | | | | | | | | | | | |
Basic weighted average shares outstanding | | | 34,845 | | | | | | | | 3,651 | | | G | | | 38,496 | |
Diluted weighted average shares outstanding | | | 39,018 | | | | | | | | 3,651 | | | G | | | 42,669 | |
Ebix, Inc. and Subsidiaries
Unaudited Pro Forma Condensed and Combined Balance Sheets
as of December 31, 2010
(In thousands)
| | | | | | | | | | | | | | | �� | | | |
| | | | | | | | | | | | | | | | Ebix/ADAM | |
| | As Reported | | | Audited | | | Adjustments | | Combined & Adjusted | |
| | Ebix, Inc. | | | ADAM | | | Amount | | | Ref | | Pro Forma | |
ASSETS | | | | | | | | | | | | | | | | | | |
Current assets: | | | | | | | | | | | | | | | | | | |
Cash and cash equivalents | | $ | 23,397 | | | $ | 7,882 | | | $ | (730 | ) | | K | | $ | 28,225 | |
| | | | | | | | | | | (1,380 | ) | | L | | | | |
| | | | | | | | | | | (944 | ) | | A | | | | |
Short-term investments | | | 6,300 | | | | — | | | | | | | | | | 6,300 | |
Trade accounts receivable, net | | | 26,028 | | | | 2,748 | | | | | | | | | | 28,776 | |
Other current assets | | | 5,057 | | | | 1,216 | | | | | | | | | | 6,273 | |
| | | | | | | | | | | | | | |
Total current assets | | | 60,782 | | | | 11,846 | | | | (3,054 | ) | | | | | 69,574 | |
| | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
Property and equipment, net | | | 7,806 | | | | 1,506 | | | | | | | | | | 9,312 | |
Goodwill | | | 180,602 | | | | 13,690 | | | | (13,690 | ) | | C | | | 250,584 | |
| | | | | | | | | | | 7,993 | | | F/K | | | | |
| | | | | | | | | | | 61,989 | | | B | | | | |
Intangibles, net | | | 22,574 | | | | 8,976 | | | | (8,976 | ) | | C | | | 41,664 | |
| | | | | | | | | | | 19,090 | | | B | | | | |
Indefinite-lived intangibles | | | 30,552 | | | | — | | | | | | | | | | 30,552 | |
Other assets | | | 984 | | | | 3,971 | | | | | | | | | | 4,955 | |
| | | | | | | | | | | | | | |
Total assets | | $ | 303,300 | | | $ | 39,989 | | | $ | 63,352 | | | | | $ | 406,641 | |
| | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
LIABILITIES AND STOCKHOLDERS’ EQUITY | | | | | | | | | | | | | | | | | | |
Current liabilities: | | | | | | | | | | | | | | | | | | |
Accounts payable and accrued liabilities | | $ | 15,344 | | | $ | 3,200 | | | | | | | | | $ | 18,544 | |
Accrued payroll and related benefits | | | 4,536 | | | | — | | | | | | | | | | 4,536 | |
Short term debt | | | 5,000 | | | | — | | | | | | | | | | 5,000 | |
Current portion of convertible debt, net | | | 4,944 | | | | — | | | | | | | | | | 4,944 | |
Current portion of long term debt and capital lease obligations | | | 426 | | | | 27 | | | | | | | | | | 453 | |
Deferred revenue | | | 8,610 | | | | 7,095 | | | | (1,849 | ) | | J | | | 13,856 | |
Other current liabilities | | | 225 | | | | — | | | | | | | | | | 225 | |
| | | | | | | | | | | | | | |
Total current liabilities | | | 39,085 | | | | 10,322 | | | | (1,849 | ) | | | | | 47,558 | |
| | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
Revolving line of credit | | | 25,000 | | | | — | | | | | | | | | | 25,000 | |
Long term debt and capital lease obligations | | | 205 | | | | 63 | | | | | | | | | | 268 | |
Deferred tax liability, net | | | 3,534 | | | | — | | | | 7,214 | | | F | | | 10,748 | |
Put option liability | | | 537 | | | | — | | | | | | | | | | 537 | |
Deferred revenue | | | 126 | | | | — | | | | | | | | | | 126 | |
Deferred rent | | | 554 | | | | — | | | | | | | | | | 554 | |
Other liabilities | | | 2,991 | | | | 646 | | | | 849 | | | M | | | 4,486 | |
| | | | | | | | | | | | | | |
Total Liabilities | | | 72,032 | | | | 11,031 | | | | 6,214 | | | | | | 89,277 | |
| | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
Stockholders’ equity: | | | | | | | | | | | | | | | | | | |
Preferred stock | | | — | | | | — | | | | | | | | | | — | |
Common stock | | | 3,602 | | | | 119 | | | | (119 | ) | | I | | | 3,967 | |
| | | | | | | | | | | 365 | | | A | | | | |
Additional paid-in-capital | | | 153,221 | | | | 64,538 | | | | (64,538 | ) | | I | | | 240,332 | |
| | | | | | | | | | | 87,111 | | | A | | | | |
Treasury stock | | | (76 | ) | | | (1,088 | ) | | | 1,088 | | | I | | | (76 | ) |
Retained earnings (deficit) | | | 67,642 | | | | (34,611 | ) | | | 34,611 | | | I | | | 66,262 | |
| | | | | | | | | | | (1,380 | ) | | L | | | | |
Accumulated other comprehensive income | | | 6,879 | | | | — | | | | | | | | | | 6,879 | |
| | | | | | | | | | | | | | |
Total stockholders’ equity | | | 231,268 | | | | 28,958 | | | | 57,138 | | | | | | 317,364 | |
| | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
Total liabilities and stockholders’ equity | | $ | 303,300 | | | $ | 39,989 | | | $ | 63,352 | | | | | $ | 406,641 | |
| | | | | | | | | | | | | | |
Notes to Unaudited Pro Forma Condensed Combined Financial Statements
1. | | Basis of Presentation |
|
| | Effective February 4, 2011, Ebix, Inc. (“Ebix” or the “Company”) acquired A.D.A.M., Inc. (“ADAM”), a leading provider of health information and benefit technology solutions in the United States, on a debt free basis for aggregate consideration in the approximate amount of $88.4 million. Under the terms of the merger agreement, ADAM shareholders received, at a fixed exchange ratio, 0.3122 shares of Ebix common stock for every share of ADAM common stock. Ebix issued approximately 3,650,914 shares of Ebix common stock pursuant to the merger. In addition Ebix paid approximately $944 thousand in cash for unexercised options. |
|
| | The accompanying unaudited condensed financial statements present the pro forma results of operations and the financial position of Ebix and ADAM on a combined basis and are based on the historical financial information of each company after giving effect to the acquisition. The unaudited pro forma combined balance sheet has been prepared assuming the acquisition of ADAM occurred on December 31, 2010. The unaudited pro forma combined statements of income have been prepared assuming the acquisition of ADAM occurred on January 1, 2010. |
|
| | The unaudited pro forma condensed and combined financial statements are based on estimates and assumptions which are preliminary and have been made solely for the purposes of developing such pro forma information. The pro forma adjustments arising from the merger are derived from the estimated fair value of the identifiable assets acquired and liabilities assumed as of February 4, 2011, and the related allocation of the purchase price consideration. The excess of the purchase price over the fair value of net assets acquired is allocated to goodwill. A summary of the estimated purchase price allocation to the fair value of assets acquired and liabilities assumed is as follows (in thousands): |
| | | | |
|
Purchase Price: | | | | |
Cash consideration | | $ | 944 | |
Common stock consideration | | | 87,476 | |
Qualified acquisition related costs | | | 730 | |
| | | |
| | $ | 89,150 | |
| | | |
| | | | |
Allocation of Purchase Price as of February 4, 2011: | | | | |
Tangible assets (net) | | $ | 8,920 | |
Identifiable intangible assets | | | 19,090 | |
Facility lease obligation | | | (849 | ) |
Goodwill | | | 61,989 | |
| | | |
| | $ | 89,150 | |
| | | |
| | The amount allocated to the intangible assets is based on the estimated fair value of the identifiable intangible assets acquired from ADAM, which include customer relationships, developed technology, and trademarks. The recording of these identifiable intangible assets resulted in the establishment of an associated deferred tax liability in the amount of $7.2 million. |
|
2. | | Pro Forma Adjustments — related to the acquisitions of ADAM in February 2011. |
|
| | Pro forma adjustments reflect only those adjustments that are factually supportable and do not include the impact of contingencies that will not be known until the resolution of the contingency.No effect has been given in these pro forma financial statements for future synergistic benefits that may be realized through the combination of the two companies or costs that may be incurred by integrating their operations. The following are brief descriptions of each of the referenced pro forma adjustments included in these unaudited condensed and combined financial statements. |
| (A) | | Reflects the consideration paid for the purchase of ADAM ($88.4 million) consisting of $944 thousand in cash with respect to unexercised ADAM stock options, and 3,650,914 shares of Ebix common stock with a value of $23.96 per share based upon the closing price on February 4, 2011. |
| (B) | | Reflects the establishment of goodwill and other intangible assets in the amounts of $62.0 million and $19.1 million respectively in connection with the acquisition of ADAM. The estimated identifiable intangible assets and their related estimated useful lives are as follows: |
| | | | | | | | | | | | |
| | Fair Value | | | Percent of | | | Remaining | |
Intangible Assets | | (In Thousands) | | | Purchase Price | | | Useful Life | |
| | | | | | | | | | | | |
Developed Technology | | $ | 890 | | | | 1 | % | | 7 years |
Health Information Content | | $ | 1,260 | | | | 1 | % | | 12 years |
Customer Relationships | | $ | 15,020 | | | | 17 | % | | 10 - 12 years |
Trademarks | | $ | 1,920 | | | | 2 | % | | 3 - 15 years |
| (C) | | Eliminates $9.0 million of pre-existing intangible assets and $13.7 million of goodwill of ADAM which were recognized in connection with prior business acquisitions that ADAM had completed |
|
| (D) | | Reflects assumed amortization expense of $1.6 million for the year ended December 31, 2010 in connection with the recognition of acquired amortizable intangible assets |
|
| (E) | | Removes interest expense in the amount $312 thousand in regards to pre-existing ADAM bank debt, as this obligation was fully satisfied prior the acquisition by Ebix. |
|
| (F) | | To record a deferred tax liability in the amount of $7.2 million thousand for the book versus tax differences attributable to acquired intangible assets. |
|
| (G) | | Increases the number of Ebix basic and diluted shares of common stock by 3,650,914 to give effect to the shares issued as purchase consideration in connection with the acquisition of ADAM |
|
| (H) | | To record the tax effect of the pro forma adjustments, resulting in a tax benefit in the amount of $404 thousand |
|
| (I) | | To eliminate the equity balances of ADAM |
|
| (J) | | To adjust the acquired deferred revenue from ADAM’s to reflect the fair value of the remaining contractual obligations |
|
| (K) | | Reflects payment of qualified acquisition related costs in the amount of $730 thousand pertaining to employment contract severance obligations and legal fees in connection with the registration of the Ebix common shares tendered as part of the acquisition consideration |
|
| (L) | | Reflects payment of investment banking fee in the amount of $1.4 million in connection with the closing of the Ebix/ADAM merger |
|
| (M) | | Represents the present value of that portion of ADAM’s facility lease obligation that is above current market rates. |